astrocytoma, grade iv
Showing 1 - 15 of 15
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Compliance, Patient, Glioblastoma, Astrocytoma, Grade IV Trial (Psychological intervention)
Not yet recruiting
- Compliance, Patient
- +2 more
- Psychological intervention
- (no location specified)
Aug 23, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)
Active, not recruiting
- Grade III Astrocytoma
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 9, 2022
Vascular Habitats Within Astrocytoma Grade 4 at Molecular,
Recruiting
- Astrocytoma, Grade IV
- +7 more
-
Valencia, SpainBiomedical Data Science Lab. Universitat Politècnica de València
May 11, 2022
Prospective Validation of Imaging Biomarkers Calculated at
Recruiting
- Astrocytoma, Grade IV
-
Valencia, SpainUniversitat Politècnica de València
Feb 7, 2022
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,
Recruiting
- Glioblastoma Multiforme
- +4 more
- pp65-shLAMP DC with GM-CSF
- +4 more
-
Gainesville, Florida
- +2 more
Jan 6, 2022
18F-FEC for Positron Emission Tomography-Computed Tomography
Withdrawn
- Astrocytoma, Grade IV
- +2 more
- External-beam radiation therapy
- Temozolomide
- (no location specified)
Jul 21, 2020
Glioblastoma, Astrocytoma, Grade IV Trial in Baltimore, New York (EGFR(V)-EDV-Dox)
Unknown status
- Glioblastoma
- Astrocytoma, Grade IV
-
Baltimore, Maryland
- +1 more
Aug 27, 2019
Glioblastoma Multiforme, Astrocytoma, Grade IV Trial in Saint Louis (Personalized peptide vaccine, Poly-ICLC, Temozolomide)
Terminated
- Glioblastoma Multiforme
- Astrocytoma, Grade IV
- Personalized peptide vaccine
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 15, 2017
Glioblastoma, Astrocytoma, Grade IV Trial in United States (XL765 (SAR245409), XL147 (SAR245408))
Completed
- Glioblastoma
- Astrocytoma, Grade IV
- XL765 (SAR245409)
- XL147 (SAR245408)
-
Los Angeles, California
- +3 more
Jul 26, 2012